Stock Analysis on Net
Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Common-Size Balance Sheet: Assets

Biogen Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Cash and cash equivalents 9.47 5.41 10.70 4.84 6.65
Marketable securities 6.45 5.19 5.74 9.15 8.94
Accounts receivable, net 6.49 7.77 6.90 7.74 7.56
Due from anti-CD20 therapeutic programs 1.73 1.68 2.17 2.08 2.25
Inventory 5.66 4.34 2.95 3.68 3.82
Other current assets 3.10 3.58 2.32 2.72 4.07
Current assets 32.90% 27.97% 30.78% 30.21% 33.29%
Marketable securities 3.74 3.14 5.17 5.44 12.93
Property, plant and equipment, net 14.31 13.86 11.92 14.24 13.45
Operating lease assets 1.57 1.76 1.57 0.00 0.00
Intangible assets, net 9.30 12.53 12.95 12.34 16.40
Goodwill 24.13 23.41 21.14 22.56 19.59
Deferred tax asset 5.93 5.56 11.87 8.52 2.52
Investments and other assets 8.12 11.78 4.60 6.69 1.82
Long-term assets 67.10% 72.03% 69.22% 69.79% 66.71%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Biogen Inc. current assets as a percentage of total assets decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Biogen Inc. property, plant and equipment, net as a percentage of total assets increased from 2019 to 2020 and from 2020 to 2021.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Biogen Inc. long-term assets as a percentage of total assets increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.